HER2-Positive Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

Featuring perspectives from Dr Adam M Brufsky, including the following topics:

• Review of Local Therapy (0:00)
• Treatment Advances for HER2 Positive Early-Stage Breast Cancer (18:35)
• Case: A woman in her early 60s with ER-positive, HER2-positive (IHC 3+) with infiltrating ductal carcinoma who received T-DM1 with an aromatase inhibitor (19:37)
• Case: A woman in her early 50s with ER-positive, HER2-positive (IHC 3+) who received TCHP followed by a mastectomy (56:26)
• Beyond the Guidelines Survey and HERRISK (1:02:23)
• Trials in Progress (1:14:44)

CME information and select publications